Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Certificate under Regulation 40(9) of the SEBI (LODR) Regulations,2015- NSE Ltd – March 31,2018
March 31, 2018
Audited Financial results for the year ended March 31,2018
March 31, 2018
Outcome of meeting - March 05,2018-BSE (2)
March 5, 2018
Outcome of meeting - March 05,2018-NSE (2)
March 5, 2018
Outcome of meeting - March 05,2018-BSE
March 5, 2018
Outcome of meeting - March 05,2018-NSE
March 5, 2018
Intimation under Regulation 30 of the SEBI (LODR) Regulations,2015-Extension of Moratorium-January 19,2018
January 19, 2018
Corporate Governance Report -Quarter ended December 31,2017- NSE AND BSE
December 31, 2017
Publication for submission of Expression of Interest under IBC,2016- NSE- November 16,2017
November 16, 2017
Publication for submission of Expression of Interest under IBC,2016- BSE- November 16,2017
November 16, 2017
Intimation to NSE- Appointment of Resolution Professional under IBC,2016-November 16,2017
November 16, 2017
Intimation to BSE- Appointment of Resolution Professional under IBC,2016-November 16,2017
November 16, 2017
Certificate under Regulation 40(9) of the SEBI (LODR) Regulations,2015-BSE-October 26,2017
October 26, 2017
Certificate under Regulation 40(9) of the SEBI (LODR) Regulations,2015-NSE-October
October 26, 2017
Certificate under Regulation 7(3) of the SEBI (LODR) Regulations,2015-BSE-October 25,2017
October 25, 2017
Certificate under Regulation 7(3) of the SEBI (LODR) Regulations,2015-NSE-October 25,2017
October 25, 2017
Previous
1
...
Next
31 / 36